3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
7
Recruiting
2
Not yet recruiting
2
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
2
Other
1
Conditions
Motor Activity
13
Neoplasms
9
Lung Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Disease
2
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Psychological Well-Being
1
Prostatic Neoplasms
1
Personal Satisfaction
1
Peripheral Nervous System Diseases
1
Pelvic Floor Disorders
1
Ovarian Neoplasms
1
Obesity
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Muscular Atrophy
1
Mesothelioma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Esophageal Neoplasms
1
Edema
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cardiotoxicity
1
Carcinoma, Non-Small-Cell Lung
1
Cancer Patients
1
Cachexia
1
Interventions
blinatumomab
10
Cyclophosphamide
6
fludarabine
4
Vincristine
4
Methotrexate
4
Dexamethasone
4
Cytarabine
4
venetoclax
3
Whole-Body Irradiation
2
Thiotepa
2
Therapeutics
2
Mercaptopurine
2
Exercise
2
Busulfan
2
ruxolitinib
1
revumenib
1
ponatinib
1
pegaspargase
1
olverembatinib
1
navitoclax
1
fludarabine phosphate
1
etoposide phosphate
1
capivasertib
1
asciminib
1
Ultrasonography
1
Transplantation
1
Prednisolone
1
Melphalan
1
Levofloxacin
1
Imatinib Mesylate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Exercise
×
Clear all
NCT07042932
2025-06-29
OPAC-ALL
Rigshospitalet, Denmark
Phase NA
Not yet recruiting
82 enrolled
NCT06846294
2025-02-26
BREVARY
University of Exeter
Phase NA
Not yet recruiting
90 enrolled